paediatric

Broker's Calls

Singapore Medical Group's outlook seen as rosy with latest acquisition

SINGAPORE (Oct 20): Maybank Kim Eng is maintaining its “buy” call on Singapore Medical Group with an unchanged target price of 78 cents which is pegged at 27 times FY18 earnings.
×